# Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.

> **NCT06463353** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Yueyang Integrated Medicine Hospital** · enrollment: 376 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **OTHER:** trilinolein cream group
- **OTHER:** cream base group

## Key facts

- **NCT ID:** NCT06463353
- **Lead sponsor:** Shanghai Yueyang Integrated Medicine Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 376 (ESTIMATED)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06463353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06463353, "Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06463353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*